Melanie B. Thomas

5.7k total citations
83 papers, 4.3k citations indexed

About

Melanie B. Thomas is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Melanie B. Thomas has authored 83 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 24 papers in Hepatology and 23 papers in Surgery. Recurrent topics in Melanie B. Thomas's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Colorectal Cancer Treatments and Studies (14 papers). Melanie B. Thomas is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Colorectal Cancer Treatments and Studies (14 papers). Melanie B. Thomas collaborates with scholars based in United States, Japan and China. Melanie B. Thomas's co-authors include Andrew X. Zhu, James L. Abbruzzese, Steven A. Curley, Ahmed O. Kaseb, Katrina Y. Glover, Romil Chadha, Jeffrey S. Morris, Yehuda Z. Patt, Manal M. Hassan and Eddie K. Abdalla and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Melanie B. Thomas

79 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie B. Thomas United States 34 1.6k 1.5k 1.2k 1.2k 843 83 4.3k
Chiun Hsu Taiwan 44 3.2k 2.0× 2.6k 1.7× 1.9k 1.6× 907 0.8× 1.4k 1.7× 226 7.4k
Bruce J. Giantonio United States 31 3.4k 2.0× 959 0.6× 1.3k 1.1× 729 0.6× 1.6k 1.9× 124 5.0k
Claus‐Henning Köhne Germany 27 3.1k 1.9× 1.1k 0.7× 763 0.6× 750 0.6× 1.2k 1.4× 75 4.3k
Dirk Arnold Germany 17 2.9k 1.8× 614 0.4× 859 0.7× 774 0.7× 921 1.1× 108 4.1k
Changfa Xia China 25 1.3k 0.8× 220 0.1× 1.0k 0.8× 684 0.6× 813 1.0× 94 3.5k
Amina Amadou France 15 1.0k 0.6× 1.1k 0.7× 1.5k 1.2× 276 0.2× 576 0.7× 38 3.7k
Herbert H. Loong Hong Kong 30 1.5k 0.9× 393 0.3× 790 0.6× 412 0.4× 1.3k 1.6× 163 3.0k
Toshifumi Wakai Japan 44 2.2k 1.3× 774 0.5× 1.7k 1.4× 2.6k 2.2× 2.2k 2.7× 346 6.0k
Piercarlo Saletti Switzerland 29 4.3k 2.6× 753 0.5× 1.0k 0.8× 941 0.8× 2.1k 2.5× 74 5.5k
Françoise Desseigne France 22 6.6k 4.0× 507 0.3× 1.4k 1.1× 1.6k 1.4× 2.0k 2.4× 76 7.8k

Countries citing papers authored by Melanie B. Thomas

Since Specialization
Citations

This map shows the geographic impact of Melanie B. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie B. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie B. Thomas more than expected).

Fields of papers citing papers by Melanie B. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie B. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie B. Thomas. The network helps show where Melanie B. Thomas may publish in the future.

Co-authorship network of co-authors of Melanie B. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie B. Thomas. A scholar is included among the top collaborators of Melanie B. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie B. Thomas. Melanie B. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheneau, Édouard, et al.. (2025). Carbon footprint of diagnostic coronary angiography. EuroIntervention. 21(16). 977–978.
2.
Thomas, Melanie B., Maryjane Farr, L. Truby, et al.. (2024). Glucagon-like peptide-1 agonist use for obesity treatment in patients with left ventricular assist devices. SHILAP Revista de lepidopterología. 5. 100114–100114.
3.
Edwards, M. J., Melanie B. Thomas, L. Truby, et al.. (2024). Glucagon-Like Peptide-1 Agonist Use for Obesity Treatment in Patients with Left Ventricular Assist Devices. The Journal of Heart and Lung Transplantation. 43(4). S23–S23.
4.
Thomas, Melanie B., et al.. (2024). S3021 A Case of an Anal Canal Lymphangioma. The American Journal of Gastroenterology. 119(10S). S2060–S2060.
5.
Patel, Devika, et al.. (2022). Facilitating Integrated Perinatal Care for Families Affected by Substance Use. Journal of Addiction Medicine. 17(1). 1–3. 1 indexed citations
6.
Simonelli, Matteo, Paolo Andrea Zucali, Armando Santoro, et al.. (2016). Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma. Annals of Oncology. 27(9). 1782–1787. 31 indexed citations
7.
Kaseb, Ahmed O., Elizabeth Garrett‐Mayer, Joanna S. Morris, et al.. (2012). Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial. Oncology. 82(2). 67–74. 75 indexed citations
8.
Yang, Yang, Patrick D. Mauldin, Myla Ebeling, et al.. (2012). Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer. 119(8). 1512–1520. 64 indexed citations
9.
Park, Joong‐Won, Richard S. Finn, Mark Karwal, et al.. (2011). Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 17(7). 1973–1983. 110 indexed citations
10.
Dale, Allan, Karen Vella, Petina L. Pert, et al.. (2011). Conceptualising, evaluating and reporting social resilience in vulnerable regional and remote communities facing climate change in tropical Queensland : marine and tropical sciences research facility transition project final report. QUT ePrints (Queensland University of Technology). 1 indexed citations
11.
Thomas, Melanie B., David A. King, Diane Keogh, Armando Apan, & Shahbaz Mushtaq. (2011). Resilience to Climate Change Impacts: A Review of Flood Mitigation Policy in Queensland, Australia: Based on Case Studies of Flood Events in 2008. Australian Journal of Emergency Management. 26(1). 9. 3 indexed citations
12.
Thomas, Melanie B.. (2009). Toward improved outcomes in hepatocellular carcinoma: overcoming the challenges of an "orphan" tumor.. PubMed Central. 1 indexed citations
13.
Thomas, Melanie B.. (2009). Molecular targeted therapy for hepatocellular carcinoma. Journal of Gastroenterology. 44(S19). 136–141. 86 indexed citations
14.
Lozano, Richard D., Thomas D. Brown, Yehuda Z. Patt, et al.. (2008). A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 134(12). 1325–1335. 21 indexed citations
15.
Hassan, Manal M., Melanie B. Thomas, Steven A. Curley, et al.. (2008). The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States. Journal of Hepatology. 50(2). 334–341. 64 indexed citations
16.
Hoff, Paulo M., Scott Kopetz, Melanie B. Thomas, et al.. (2008). A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer. British Journal of Cancer. 99(5). 722–726. 1 indexed citations
17.
Thomas, Melanie B., Romil Chadha, Katrina Y. Glover, et al.. (2007). Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer. 110(5). 1059–1067. 235 indexed citations
18.
Ribero, Dario, Huamin Wang, Matteo Donadon, et al.. (2007). Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases. Cancer. 110(12). 2761–2767. 278 indexed citations
19.
Shaib, Yasser H., Hashem B. El‐Serag, Ajay K. Nooka, et al.. (2007). Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Hospital-Based Case?Control Study. The American Journal of Gastroenterology. 102(5). 1016–1021. 199 indexed citations
20.
Pawlik, Timothy M., Charles R. Scoggins, Melanie B. Thomas, & Jean‐Nicolas Vauthey. (2004). Advances in the Surgical Management of Liver Malignancies. The Cancer Journal. 10(2). 74–87. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiun Hsu Breakdown of academic impact, for papers by Bruce J. Giantonio Breakdown of academic impact, for papers by Claus‐Henning Köhne Breakdown of academic impact, for papers by Dirk Arnold Breakdown of academic impact, for papers by Changfa Xia Breakdown of academic impact, for papers by Amina Amadou Breakdown of academic impact, for papers by Herbert H. Loong Breakdown of academic impact, for papers by Toshifumi Wakai Breakdown of academic impact, for papers by Piercarlo Saletti Breakdown of academic impact, for papers by Françoise Desseigne
Rankless by CCL
2026